For treatment of some breast cancers, 2 drugs approved by European Union

Enhertu is a specifically engineered HER2-directed antibody drug conjugate (ADC) being jointly developed and commercialised by AstraZeneca and Daiichi Sankyo.

from mint - Science https://ift.tt/fuAKT7w
https://ift.tt/ciUbzLR